Alamar HoldCo, LLC has officially reported owning a 7.1% stake in Attovia Therapeutics, Inc., as per a recent filing with the SEC. This significant ownership position may reflect Alamar's growing interest in the biological products sector, which is characterized by innovation and competition.

Background

Alamar HoldCo, LLC is a Delaware limited liability company based in Fremont, California. The company focuses on strategic investments and has recently made headlines with its stake in Attovia Therapeutics, Inc., which operates in the biological products sector. Attovia is incorporated in Delaware and is headquartered in San Carlos, California.

What the Filing Says

The SEC filing, dated November 13, 2026, indicates that Alamar HoldCo beneficially owns 3,229,278 shares of Attovia's common stock. This stake represents 7.1% of the company's outstanding shares, calculated based on 45,651,262 total shares reported in Attovia's Form 10-Q filed on September 2, 2026.

Impact

This ownership may have implications for both Alamar and Attovia, as it positions Alamar as a significant stakeholder in Attovia's future. The filing suggests that Alamar has sole voting and dispositive power over the shares, indicating a strong influence in corporate decisions.

What's Next

The filing does not say what happens next.

Company Details

Attovia Therapeutics, Inc. is classified under the Standard Industrial Classification (SIC) code 2836, which pertains to biological products excluding diagnostic substances. The company is incorporated in Delaware and has its principal executive office located at 1091 Industrial Road, Suite 310, San Carlos, California, with a fiscal year ending on December 31.

Ownership Structure

According to the filing, Alamar HoldCo, LLC is the record owner of the 3,229,278 shares of Attovia's common stock, which it beneficially owns. This ownership gives Alamar sole voting power and sole dispositive power over the shares, with no shared voting or dispositive power reported.

Filing Context

The filing was submitted under Rule 13d-1(d) of the SEC regulations, which pertains to the reporting of beneficial ownership of securities. This rule requires entities that acquire more than 5% of a company's shares to file a Schedule 13G with the SEC, indicating their ownership stake and intentions.

Signatory Information

The filing was signed by Yuling Luo, who is identified as the President of Alamar HoldCo, LLC. The signature was dated November 13, 2026, which aligns with the date of the filing.